We hypothesized the existence of a systemic ¡°signature?that could distinguish ¡°vulnerable?patients with preexisting coronary atherosclerosis from those having similar risk factors and atheromatous burden, but no history of clinically evident plaque rupture/erosion.
Twenty three patients who had at least two prior myocardial infarctions (¡°vulnerable group? were matched in respect to their background and coronary atherosclerosis extent with twenty one patients without a history of previous myocardial infarction who underwent routine coronary angiography before valvular surgery. We studied a panel of cytokines, antibodies and hormones including IL-6, IL-10, IL-12, antibodies to ¦Â2 glycoprotein I (¦Â2GPI), antibodies to oxidized-LDL, adiponectin and resistin, along with levels of circulating EPCs and Tregs.
A significantly higher level of Treg cells was present in the control (73.4 % ¡À 4) than in the ¡°vulnerable patient?group (62.2 % ¡À 10.7), p < 0.001. IL-10 level was also significantly higher in the control than in the vulnerable patients (2.6 ¡À 1.2 pg/ml versus 0.9 ¡À 0.1 pg/ml respectively, p = 0.03). There was no significant difference in the circulating levels of the other cytokines, hormones or EPCs between the two groups.
Regulatory T cells and serum IL-10 may discriminate ¡°vulnerable?versus stable patients and may have a protective role against plaque rupture in patients with coronary atherosclerosis.